FDA Approves Intravenous Formulation Of Pfizer’s Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
Revatio is the Only Treatment in Its Class with Both Oral
and Intravenous Formulations
NEW YORK–(BUSINESS WIRE)–Nov 20, 2009 – Pfizer announced today
that the U.S. Food and Drug Administration (FDA) has approved
Revatio (sildenafil) Injection,…
November 21st, 2009
Posted in
NewDrugs